San Carlos, CA, United States of America

Hangjun Zhan

This inventor holds 2 USPTO granted patents. Top assignee: Attovia Therapeutics, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hangjun Zhan. Retrieved from https://idiyas.com/inventor/hangjun-zhan-rnntxu0w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Hangjun Zhan

Introduction

Hangjun Zhan is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of bispecific polypeptides. With a total of 2 patents to his name, Zhan continues to push the boundaries of scientific innovation.

Latest Patents

Zhan's latest patents include "IL13 AND IL31 BISPECIFIC POLYPEPTIDES AND USES THEREOF" and "IL31-BINDING POLYPEPTIDES AND USES THEREOF." These inventions showcase his expertise in creating targeted therapies that could have substantial implications for treating various diseases.

Career Highlights

Currently, Hangjun Zhan is employed at Attovia Therapeutics, Inc., where he applies his knowledge and skills to advance therapeutic solutions. His work at Attovia Therapeutics reflects his commitment to improving healthcare through innovative research.

Collaborations

Zhan collaborates with talented individuals such as Lam Nguyen and David Bellovin, contributing to a dynamic team focused on groundbreaking research and development.

Conclusion

Hangjun Zhan's contributions to biotechnology through his patents and work at Attovia Therapeutics highlight his role as an influential inventor in the field. His ongoing efforts are likely to lead to further advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…